Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026
Business Wire (Tue, 17-Feb 8:35 AM ET)
Cardio Diagnostics Expands with Landmark PrecisionCHD Partnership in India
Market Chameleon (Wed, 7-Jan 2:31 AM ET)
Business Wire (Wed, 7-Jan 6:25 AM ET)
Business Wire (Tue, 6-Jan 8:35 AM ET)
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Cardio Diagnostics Hldgs trades on the NASDAQ stock market under the symbol CDIO.
As of March 30, 2026, CDIO stock price declined to $1.74 with 179,082 million shares trading.
CDIO has a beta of 2.71, meaning it tends to be more sensitive to market movements. CDIO has a correlation of 0.06 to the broad based SPY ETF.
CDIO has a market cap of $5.15 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CDIO traded as high as $125.70 and as low as $.97.
The top ETF exchange traded funds that CDIO belongs to (by Net Assets): VXF.
CDIO has underperformed the market in the last year with a price return of -86.0% while the SPY ETF gained +12.7%. CDIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -47.7% and -37.9%, respectively, while the SPY returned -8.2% and -4.3%, respectively.
CDIO support price is $1.73 and resistance is $2.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDIO shares will trade within this expected range on the day.
